NTRA Insider Trading

Company officers and directors buying and selling their own stock, as reported to the SEC on Form 4.

226 open-market transactions — 0 purchases, 226 sales · 2026-07-27 to 2026-11-11

Date Ticker Insider Action Shares Price Filing
2026-11-11 NTRA Sheena Jonathan — Director Sell 240 319.77 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 240 319.22 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 182 317.96 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 160 320.02 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 145 317.87 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 120 320.07 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 85 316.93 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 80 322.88 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 48 317.33 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 40 324.76 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 40 323.07 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 40 322.00 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 40 315.28 SEC
2026-11-11 NTRA Sheena Jonathan — Director Sell 40 315.26 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 1.8K 316.87 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 169 315.48 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 131 320.07 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 110 310.17 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 108 314.71 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 105 319.30 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 106 312.20 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 100 311.31 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 74 313.32 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 64 309.08 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 56 318.17 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 51 321.12 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 51 305.75 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 50 308.20 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 45 325.05 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 40 323.86 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 21 306.46 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 16 321.85 SEC
2026-11-06 NTRA Sheena Jonathan — Director Sell 15 304.57 SEC
2026-11-03 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 470 391.49 SEC
2026-11-02 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 2.9K 415.64 SEC
2026-11-02 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 914 400.29 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 760 415.52 SEC
2026-11-02 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 731 400.29 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 520 409.46 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 432 406.94 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 408 408.08 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 410 400.29 SEC
2026-11-02 NTRA RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER Sell 334 400.29 SEC
2026-11-02 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 317 400.29 SEC
2026-11-02 NTRA Fesko John — PRESIDENT, CHIEF BUS. OFFICER Sell 295 400.29 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 240 416.45 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 200 405.26 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 120 412.88 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 120 411.73 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 120 410.72 SEC
2026-11-02 NTRA Sheena Jonathan — Director Sell 109 400.29 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 80 414.16 SEC
2026-11-02 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 21 387.90 SEC
2026-11-02 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 17 388.20 SEC
2026-11-02 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 9 388.20 SEC
2026-11-02 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 8 388.03 SEC
2026-11-02 NTRA Fesko John — PRESIDENT, CHIEF BUS. OFFICER Sell 7 388.20 SEC
2026-11-02 NTRA RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER Sell 7 388.20 SEC
2026-11-02 NTRA Sheena Jonathan — Director Sell 3 388.20 SEC
2026-10-30 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 1.9K 425.55 SEC
2026-10-28 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 3.4K 426.34 SEC
2026-10-28 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 1.2K 426.34 SEC
2026-10-28 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 1.2K 426.34 SEC
2026-10-28 NTRA RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER Sell 968 426.34 SEC
2026-10-28 NTRA Fesko John — PRESIDENT, CHIEF BUS. OFFICER Sell 898 426.34 SEC
2026-10-28 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 865 426.87 SEC
2026-10-28 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 313 425.32 SEC
2026-10-28 NTRA Sheena Jonathan — Director Sell 187 426.34 SEC
2026-10-27 NTRA Chapman Steven Leonard — CEO AND PRESIDENT Sell 2.3K 406.00 SEC
2026-10-27 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 1.7K 406.00 SEC
2026-10-27 NTRA Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS Sell 1.0K 406.00 SEC
2026-10-27 NTRA RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER Sell 884 406.00 SEC
2026-10-27 NTRA Brophy Michael Burkes — CHIEF FINANCIAL OFFICER Sell 781 406.00 SEC
2026-10-27 NTRA Fesko John — PRESIDENT, CHIEF BUS. OFFICER Sell 781 406.00 SEC
2026-10-27 NTRA Sheena Jonathan — Director Sell 291 406.00 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 962 408.26 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 627 409.89 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 605 411.32 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 255 415.67 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 211 412.20 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 200 406.50 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 165 416.67 SEC
2026-10-21 NTRA Sheena Jonathan — Director Sell 125 413.05 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 280 401.29 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 280 400.68 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 215 399.34 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 142 398.95 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 98 409.34 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 90 404.25 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 90 403.70 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 80 409.36 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 80 406.06 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 60 401.62 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 50 405.15 SEC
2026-10-16 NTRA Sheena Jonathan — Director Sell 35 406.63 SEC
2026-10-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 10.3K 404.64 SEC
2026-10-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 6.3K 405.18 SEC
2026-10-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 6.3K 402.23 SEC
2026-10-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 6.0K 401.42 SEC
2026-10-15 NTRA Rabinowitz Matthew — EXECUTIVE CHAIRMAN Sell 3.9K 403.27 SEC

What Form 4 actually tells you

Officers, directors and anyone holding more than 10% of a company must report trades in its stock to the SEC within two business days, on Form 4. The filings are public the moment they land, and every row above links to the original.

Buys and sells are not symmetric

This is the thing worth internalising. An insider sells for a hundred reasons that say nothing about the company — diversification, a house, a tax bill, or a pre-scheduled 10b5-1 plan set up months earlier. An insider buying on the open market with their own money has exactly one obvious motive.

Which is why this page shows only open-market purchases and sales. Form 4 also reports option grants, option exercises and shares withheld to cover taxes; those are compensation mechanics, and screens that fold them in produce noise that looks like signal.

Why cluster buying is the part worth watching

A single insider buying tells you very little. They may be topping up after a sale, converting a bonus, or simply buying because they always buy in January. The signal researchers actually find informative is a cluster: several different insiders at the same company, buying on the open market, independently, inside a short window.

That is hard to explain away as personal circumstance. It usually means several people with the same non-public view of the business reached the same conclusion at once. The table above lists companies where three or more distinct insiders bought within 90 days — and it is worth noting how short that list usually is. Genuine clusters are rare, which is rather the point.

Timing and limits

Where this comes from

Parsed directly from SEC EDGAR — the daily filing index, then each Form 4's XML. Public domain, no vendor in between, which is why the original filing can be linked from every row.